Changes in autism spectrum disorder prevalence in 4 areas of the United States
To access this article, please choose from the options below
Financial disclosure: Dr. Rice conducts a limited number of training sessions to professionals on the diagnosis of the autism spectrum disorders as an approved outside activity separate from employment with the Federal government. The other authors report no conflicts of interest. The authors acknowledge the collaborative work of the Autism and Developmental Disabilities Monitoring (ADDM) Network dedicated project staff who contributed to the data collection for this manuscript. The participation and support from the many educational and clinical programs and data sources have been invaluable. Catherine Lord, Ph.D. (University of Michigan), Gail McGee, Ph.D., and Michael Morrier, Ph.D. (Emory University) provided expertise related to the case definition. Diana Schendel, Coleen Boyle, Esther Sumartojo, Ed Trevathan, and Carole Craft reviewed the manuscript and gave editorial assistance. Sydney Pettygrove, Catherine Rice, Jon Baio, Li-Ching Lee, and Joyce Nicholas had full access to all of the data in their study site and take responsibility for the integrity of the data and the accuracy of the data analysis. These projects were funded by the Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. For additional information on these projects, see http://www.cdc.gov/autism.
PII: S1936-6574(09)00192-7
doi:10.1016/j.dhjo.2009.10.008
Published by Elsevier Inc.
